Clinical Research Facility
				
				Danville, Pennsylvania
We've found
        9 trials
        at this facility
      Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  The Product Surveillance Registry REVERSE Post Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  	
	Lymphoma,Non-Hodgkin Clinical Trial
	
Updated: 12/31/1969
  
  
  Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	MPN (Myeloproliferative Neoplasms) Clinical Trial
	
Updated: 12/31/1969
  
  
  Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Otolaryngology Clinical Trial
	
Updated: 12/31/1969
  
  
  Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Gastroenterology, Nephrology / Urology, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Product Surveillance Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Rhythm Disorder Clinical Trial
	
Updated: 5/2/2018
  
  
  3T MRI CIED Post-Approval Study
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 5/2/2018
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	